Maruyama K, Ye C L, Woo M, Venkatacharya H, Lines L D, Silver M M, Rabinovitch M
Department of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada.
Am J Physiol. 1991 Dec;261(6 Pt 2):H1716-26. doi: 10.1152/ajpheart.1991.261.6.H1716.
Previously in rats injected with the toxin monocrotaline and administered SC-39026, a serine elastase inhibitor, pulmonary hypertension was decreased in association with reduced muscularization of peripheral pulmonary arteries. To determine whether inhibition of elastolytic activity might prevent this vascular change in other conditions producing pulmonary hypertension, we administered SC-39026 to rats during a 10-day exposure to chronic hypobaric hypoxia. We also measured elastolytic activity in the central pulmonary arteries of rats using [3H]elastin substrate and determined whether there was an increase in activity either as early as 2 days or at completion of the hypoxic exposure, which could be inhibited by SC-39026. to further determine whether the mechanism of muscularization of peripheral arteries is modulated by degradation of elastin or other elastase-susceptible extracellular matrix proteins, we assessed desmosine excretion and ultrastructural alterations in elastin as well as in type IV collagen, fibronectin, and laminin. SC-39026 reduced the number of muscularized arteries and the level of pulmonary arterial pressure during exposure to chronic hypoxia. Elastolytic activity was fourfold higher in central pulmonary arteries 2 days after hypoxia when compared with values in control vessels, and the activity was inhibited by SC-39026. In small peripheral pulmonary arteries there were no significant changes with hypoxia reflected in desmosines or in the immunocytochemistry of elastase-susceptible glycoproteins, with the exception of decreased laminin. This feature was not inhibited by SC-39026. To further assess whether the protective effect of SC-39026 was related to its inhibition of elastase, an extended study was carried out using a different elastase inhibitor, alpha 1-proteinase inhibitor. An even greater reduction in hypoxia-induced pulmonary hypertension and vascular changes was observed with this elastase inhibitor and the latter included medial hypertrophy.
先前在注射了毒素野百合碱并给予丝氨酸弹性蛋白酶抑制剂SC - 39026的大鼠中,肺动脉高压有所降低,同时外周肺动脉的肌化程度也降低。为了确定抑制弹性蛋白酶活性是否能预防其他导致肺动脉高压的情况下的这种血管变化,我们在大鼠暴露于慢性低压低氧环境10天期间给予SC - 39026。我们还使用[3H]弹性蛋白底物测量了大鼠中央肺动脉中的弹性蛋白酶活性,并确定在低氧暴露2天或结束时活性是否增加,以及这种增加是否能被SC - 39026抑制。为了进一步确定外周动脉肌化的机制是否由弹性蛋白或其他易受弹性蛋白酶作用的细胞外基质蛋白的降解所调节,我们评估了弹性蛋白以及IV型胶原、纤连蛋白和层粘连蛋白中的锁链素排泄和超微结构改变。SC - 39026减少了慢性低氧暴露期间肌化动脉的数量和肺动脉压水平。与对照血管相比,低氧2天后中央肺动脉中的弹性蛋白酶活性高四倍,且该活性被SC - 39026抑制。在小的外周肺动脉中,除层粘连蛋白减少外,低氧在锁链素或易受弹性蛋白酶作用的糖蛋白的免疫细胞化学方面没有显著变化。这一特征未被SC - 39026抑制。为了进一步评估SC - 39026的保护作用是否与其对弹性蛋白酶的抑制有关,我们使用另一种弹性蛋白酶抑制剂α1 - 蛋白酶抑制剂进行了一项扩展研究。使用这种弹性蛋白酶抑制剂观察到低氧诱导的肺动脉高压和血管变化有更大程度的降低,后者包括中层肥厚。